SeaCrest Wealth Management »

Bioxcel Therapeutics shares owned by SeaCrest Wealth Management

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by SeaCrest Wealth Management from 13F filings

Historical chart of SeaCrest Wealth Management investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by SeaCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by SeaCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $49k 17k 2.82
2023-12-31 $51k 18k 2.81
2023-09-30 $42k 17k 2.53
2023-06-30 $138k 21k 6.66
2023-03-31 $278k 15k 18.66